Expression of facilitative glucose transporter 1 mRNA in colon cancer was not regulated by k-ras

Cancer Letters

Volumn 154, Issue 2, 2000, Pages 137-142

  Noguchi, Yoshikazu ^a   Okamoto, Takahide ^a   Marat, Doulet ^a   Yoshikawa, Takaki ^a   Saitoh, Aya ^a   Doi, Chiharu ^a   Fukuzawa, Kuniyasu ^a   Tsuburaya, Akira ^a   Satoh, Shinobu ^a   Ito, Takaaki ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Facilitative glucose transporters; k ras; Mutant allele specific amplification; Quantitative competitive PCR

Indexed keywords

GLUCOSE TRANSPORTER;

ALLELE; ARTICLE; CLINICAL ARTICLE; COLON ADENOCARCINOMA; COLON CANCER; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MALIGNANT TRANSFORMATION; ONCOGENE K RAS; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOCARCINOMA; COLON; COLONIC NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, RAS; GLUCOSE TRANSPORTER TYPE 1; GLUCOSE TRANSPORTER TYPE 2; GLUCOSE TRANSPORTER TYPE 3; GLUCOSE TRANSPORTER TYPE 4; GLUCOSE TRANSPORTER TYPE 5; HUMANS; MONOSACCHARIDE TRANSPORT PROTEINS; MUCOUS MEMBRANE; MUSCLE PROTEINS; NERVE TISSUE PROTEINS; POINT MUTATION; RAS PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0034733958     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(00)00354-2     Document Type: Article

References (22)

1. O. Warburg, The Metabolism of Tumors, Richard R. Smith, New York, 1931, pp. 29-169.
2. Burant C.F., Sivitz W.I., Fukumoto H., Kayanoa T., Nagamatsu S., Seino S., Pessin J.E., Bell G.I. Mammalian glucose transporters: structure and molecular regulation. Rec. Prog. Horm. Res. 47:1991;349-388.
3. Ito T., Noguchi Y., Satoh S., Hayashi H., Inayama Y., Kitamura H. Expression of facilitative glucose transporter isoforms in lung carcinoma: its relation to histologic type, differentiation grade, and tumor stage, Modern Pathol. 11:1998;437-443.
4. Rollins B.J., Mossison E.D., Usher P., Flier J.S. Platelet-derived growth factor regulates glucose transporter expression. J. Biol. Chem. 263:1998;16523-16526.
5. Su T.S., Tsai T.F., Chi C.W., Han S.H., Chon C.K. Elevation of facilitated glucose-transporter messenger RNA in human hepatocellular carcinoma. Hepatology. 11:1992;118-122.
6. Noguchi Y., Yoshikawa T., Marat D., Saito A., Tsuburaya A., Doi C., Ito T., Satoh S. Expression of facilitative glucose transporters in gastric tumors. Hepatogastroenterology. 1999;. in press.
7. Mellanen P., Minn H., Grenman R., Harkonen P. Expression of glucose transporters in head-and-neck tumors. Int. J. Cancer. 56:1994;622-629.
8. Younes M., Brown R.W., Stephenson M., Gondo M., Cagle P.T. Overexpression of Glut 1 and Glut 3 in stage I nonsmall cell lung carcinoma is associated with poor survival. Cancer. 15:1997;1046-1051.
9. Brown R.S., Wahl R.L. Overexpression of Glut-1 glucose transporter in human breast cancer. Cancer. 72:1993;2979-2985.
10. Haber R.S., Rathan A., Weiser K.R., Pritsker A., Itzkowitz S.H., Bodian C., Slater G., Weiss A. Glut 1 glucose transporter expression in colorectal carcinoma: a marker for poor prognosis. Cancer. 83:1998;34-40.
11. Kahn B.B., Flier J.S. Regulation of glucose-transporter gene expression in vitro and in vivo. Diabetes Care. 13:1990;548-564.
12. Baker S.J., Preisinger A.C., Jessup J.M., Paraskeva C., Markowitz S., Willson J.K.V., Hamilton S., Vogelstein B. mutations occur in combination with 17p alleic deletions as late events in colorectal tumorigenesis. Cancer Res. 50:1990;7717-7722.
13. Takeda S., Ichii S., Nakamura Y. Detection of K-ras mutation in sputum by mutant-alle-specific amplification (MASA). Hum. Mutat. 2:1993;112-117.
14. Wheeler T.J., Finkle P.C. The glucose transporter of mammalian cells. Annu. Rev. Physiol. 47:1985;503-517.
15. Dang C.V., Semenza G.L. Oncogenic alterations of metabolism. Trends Biochem. Sci. 24:1999;68-72.
16. Binder C., Binder L., Marx D., Schauer A., Hiddemann W. Deregulation of simultaneous expression of multiple glucose transporter isoforms in malignant cells and tissues. Anticancer Res. 17:1997;4299-4304.
17. Forgue-Lafitte M.E., Horvat A., Rosselin G. Insulin binding by a cell line (HT 29) derived from human colonic cancer. Mol. Cell Endocrinol. 14:1979;123-130.
18. Franklin C.C., Chin P.C., Turner J.T., Kim H.D. Insulin regulation of glucose metabolism in HT29 colonic adenocarcinoma cells. Activation of glycolysis without augmentation of glucose transport, Biochim. Biophys. Acta. 972:1988;60-68.
19. Mathupala S.P., Heese C., Pedersen P.L. Glucose catabolism in cancer cells. The type II hexokinase promoter contains functionally active response elements for the tumor suppressor p53, J. Biol. Chem. 272:1997;22776-22780.
20. Iyer N.V., Kotch L.E., Agani F., Leung S.W., Laughner E., Wenger R.H., Gassmann M., Gearhart J.D., Lawler A.M., Yu A.Y., Semenza G.L. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev. 12:1998;149-162.
21. Flier J.S., Mueckler M.M., Usher P., Lodish H.F. Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. Science. 235:1987;1492-1495.
22. Salter D.W., Baldwin S.A., Lienhard G.E., Weber M.J. Proteins antigenically related to the human erythrocyte glucose transporter in normal and Rous sarcoma virus-transfected chicken embryo fibroblasts. Proc. Nat. Acad. Sci. USA. 79:1982;1540-1544.